GenScript Launches CloneReadyTM Gene Collections
Aug 23, 2010
PISCATAWAY, N.J., Aug 23, 2010- Internationally recognized biology contract research organization GenScript USA Inc. has launched CloneReadyTM Gene Collections for researchers to quickly and cost-effectively get genes they need.
GenScript’s CloneReadyTM Gene Collections host hundreds of thousands of popular genes from mammalian and other species. In particular, many full-length cDNA clones are included in the collection and more than 100,000 genes have been validated and guaranteed with 100% sequence fidelity. With its gene collections, GenScript’s customers can readily get their genes of interest without performing tedious cloning, sequencing, and validation procedures before directly focusing on more important downstream practices. “We help our customers get several steps closer to their goals in mind, saving both time and money.” commented Dr. Wang, VP of GenScript’s Bio-Reagent Division.
To enhance user experience, GenScript’s CloneReadyTM Gene Collections are integrated with its online gene quotation system. Customers can simply click the "Search Now!" button to start searching in the CloneReadyTM Gene Collections. Clones up to 3 kb are freely available with orders of downstream molecular biology services. In addition, new genes are constantly being added to the collection to further fulfill customers’ molecular biology needs.
GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
# # # #
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.
Your Innovation Partner in Drug Discovery!